A comprehensive evaluation of the prognostic significance of 13q deletions in patients with B-chronic lymphocytic leukaemia.

作者: Daniel L. Van Dyke , Tait D. Shanafelt , Timothy G. Call , Clive S. Zent , Stephanie A. Smoley

DOI: 10.1111/J.1365-2141.2009.07982.X

关键词:

摘要: Deletion 13q14 on fluorescence in situ hybridization (FISH) analysis is the most common cytogenetic abnormality chronic lymphocytic leukemia (CLL), and a favorable prognostic biomarker when detected as sole abnormality. We intensively interrogated clinical outcome 323 consecutive, untreated CLL patients with isolated 13q- identified within two years of diagnosis. also analyzed 217 additional deletion 11q22.3 or 17p13.1, trisomy 12 based whether these occurred isolation conjunction 13q-. Patients heterozygous those homozygous had similar time to first treatment (TFT) overall survival (OS). In contrast, higher percentage nuclei was associated significantly shorter TFT (p 65.5% (p<0.001). The exhibiting remained an independent predictor after controlling for ZAP-70, IgVH, CD38 (all p<0.001). Among plus one other FISH abnormality, concomitant appeared attenuate 17p- (p=0.019). implications appear more complex than originally appreciated.

参考文章(10)
Gordon W Dewald, Stephanie R Brockman, Sarah F Paternoster, Nancy D Bone, Judith R O'Fallon, Cristine Allmer, Charles D James, Diane F Jelinek, Renee C Tschumper, Curtis A Hanson, Rajiv K Pruthi, Thomas E Witzig, Timothy G Call, Neil E Kay, None, Chromosome anomalies detected by interphase fluorescence in situ hybridization: correlation with significant biological features of B-cell chronic lymphocytic leukaemia British Journal of Haematology. ,vol. 121, pp. 287- 295 ,(2003) , 10.1046/J.1365-2141.2003.04265.X
Constantine S. Tam, Tait D. Shanafelt, William G. Wierda, Lynne V. Abruzzo, Daniel L. Van Dyke, Susan O'Brien, Alessandra Ferrajoli, Susan A. Lerner, Alice Lynn, Neil E. Kay, Michael J. Keating, De novo deletion 17p13.1 chronic lymphocytic leukemia shows significant clinical heterogeneity: the M. D. Anderson and Mayo Clinic experience Blood. ,vol. 114, pp. 957- 964 ,(2008) , 10.1182/BLOOD-2009-03-210591
A. Cimmino, G. A. Calin, M. Fabbri, M. V. Iorio, M. Ferracin, M. Shimizu, S. E. Wojcik, R. I. Aqeilan, S. Zupo, M. Dono, L. Rassenti, H. Alder, S. Volinia, C.-g. Liu, T. J. Kipps, M. Negrini, C. M. Croce, miR-15 and miR-16 induce apoptosis by targeting BCL2. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 102, pp. 13944- 13949 ,(2005) , 10.1073/PNAS.0506654102
Cécile Contal, John O'Quigley, An application of changepoint methods in studying the effect of age on survival in breast cancer Computational Statistics & Data Analysis. ,vol. 30, pp. 253- 270 ,(1999) , 10.1016/S0167-9473(98)00096-6
Christian Chena, Julio Sánchez Avalos, Raimundo F. Bezares, Guillermo Arrossagaray, Karina Turdó, Alicia Bistmans, Irma Slavutsky, Biallelic deletion 13q14.3 in patients with chronic lymphocytic leukemia: cytogenetic, FISH and clinical studies European Journal of Haematology. ,vol. 81, pp. 94- 99 ,(2008) , 10.1111/J.1600-0609.2008.01086.X
D Catovsky, S Richards, E Matutes, D Oscier, MJS Dyer, RF Bezares, AR Pettitt, T Hamblin, DW Milligan, JA Child, MS Hamilton, CE Dearden, AG Smith, AG Bosanquet, Z Davis, V Brito-Babapulle, M Else, R Wade, P Hillmen, Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial The Lancet. ,vol. 370, pp. 230- 239 ,(2007) , 10.1016/S0140-6736(07)61125-8
J. A. Hernandez, A. E. Rodriguez, M. Gonzalez, R. Benito, C. Fontanillo, V. Sandoval, M. Romero, G. Martin-Nunez, A. G. de Coca, R. Fisac, J. Galende, I. Recio, F. Ortuno, J. L. Garcia, J. de las Rivas, N. C. Gutierrez, J. F. San Miguel, J. M. Hernandez, A high number of losses in 13q14 chromosome band is associated with a worse outcome and biological differences in patients with B-cell chronic lymphoid leukemia Haematologica. ,vol. 94, pp. 364- 371 ,(2009) , 10.3324/HAEMATOL.13862
Tait D. Shanafelt, Thomas E. Witzig, Stephanie R. Fink, Robert B. Jenkins, Sarah F. Paternoster, Stephanie A. Smoley, Kimberly J. Stockero, Danielle M. Nast, Heather C. Flynn, Renee C. Tschumper, Susan Geyer, Clive S. Zent, Tim G. Call, Diane F. Jelinek, Neil E. Kay, Gordon W. Dewald, Prospective Evaluation of Clonal Evolution During Long-Term Follow-Up of Patients With Untreated Early-Stage Chronic Lymphocytic Leukemia Journal of Clinical Oncology. ,vol. 24, pp. 4634- 4641 ,(2006) , 10.1200/JCO.2006.06.9492
Hartmut Döhner, Stephan Stilgenbauer, Axel Benner, Elke Leupolt, Alexander Kröber, Lars Bullinger, Konstanze Döhner, Martin Bentz, Peter Lichter, Genomic Aberrations and Survival in Chronic Lymphocytic Leukemia The New England Journal of Medicine. ,vol. 343, pp. 1910- 1916 ,(2000) , 10.1056/NEJM200012283432602
Stephanie Fink, Susan Geyer, Tait Shanafelt, Stephanie Smoley, Sarah Paternoster, Karin Giordano, Renee Tschumper, Diane Jelinkek, Nancy Bone, Brian Kabat, Timothy Call, Robert Phyliky, Neil Kay, Gordon Dewald, Clinical Significance of Homozygous D13S319 Deletion in B-Cell Chronic Lymphocytic Leukemia (B-CLL). Blood. ,vol. 104, pp. 2799- 2799 ,(2004) , 10.1182/BLOOD.V104.11.2799.2799